electroCore, Inc.(ECOR)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #2,487 of 2,962 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
ECOR Stock Analysis & AI Quality Score
Data updated 2026-09-11AI stock analysis and institutional research for electroCore, Inc. (ECOR), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores ECOR at 30.5/100 on a 32-signal composite quality model, placing it at rank #2,487 of 2,962 stocks — the bottom half of the AI-ranked universe. ECOR scores in the top quartile across revenue growth (90.3). Areas of concern include balance sheet strength (1.3) and revenue scale (6.7), which score below median versus the broader universe. Shareholder dilution risk is elevated at 22.2/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), electroCore, Inc. reports quarterly revenue of $9.4M, net income of $-3.1M, free cash flow of $-3.5M. Top institutional holders of ECOR by reported 13-F value include VANGUARD CAPITAL MANAGEMENT, FourWorld Capital Management, WEXFORD CAPITAL, based on the most recent SEC filings. ECOR trades on the Nasdaq exchange and files with the SEC under CIK 1560258. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ECOR daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for electroCore, Inc. directly from SEC EDGAR. electroCore, Inc.'s 13F Pro composite quality score has ranged between 25 and 32 since 2025, currently 30.5 — an improving long-term trajectory across 52 quarterly and live scoring snapshots.
Revenue
Q2 2026
$9.4M
Net Income
Q2 2026
$-3.1M
Free Cash Flow
Q2 2026
$-3.5M
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
+27.2% YoYNet Income
-17.5% YoYOperating Income
-8.1% YoYEPS (Diluted)
-3.8% YoYTotal Assets
-8.8% YoYTotal Debt
Op. Cash Flow
-17.8% YoYFree Cash Flow
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $32.0M +27.2% | $25.2M +57.1% | $16.0M +86.6% | $8.6M +57.6% | $5.5M +55.9% | $3.5M |
| Net Income | $-14.0M -17.5% | $-11.9M +36.9% | $-18.8M +15.0% | $-22.2M -28.7% | $-17.2M +26.8% | $-23.5M |
| Operating Income | $-13.2M -8.1% | $-12.2M +36.9% | $-19.3M +15.8% | $-22.9M -14.1% | $-20.0M +19.0% | $-24.7M |
| EPS (Diluted) | $-1.65 -3.8% | $-1.59 +53.5% | $-3.42 +27.1% | $-4.69 -7.6% | $-4.36 | — |
| Total Assets | $18.7M -8.8% | $20.5M +27.1% | $16.1M -35.0% | $24.8M -42.2% | $42.8M +35.9% | $31.5M |
| Total Debt | $7.8M | — | — | — | — | $1.4M |
| Operating Cash Flow | $-8.2M -17.8% | $-6.9M +52.6% | $-14.7M +11.9% | $-16.6M -22.1% | $-13.6M +32.0% | $-20.1M |
| Free Cash Flow | $-8.3M | — | $-14.9M | — | — | — |
Get alerted when ECOR's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for electroCore, Inc. including:
Top Institutional Holders of ECOR
VANGUARD CAPITAL MANAGEMENT LLC
$1.8M211,639 shFourWorld Capital Management LLC
$812.2K94,000 shWEXFORD CAPITAL LP
$795.4K92,060 shGEODE CAPITAL MANAGEMENT, LLC
$632.2K73,149 shNORTHERN TRUST CORP
$574.6K66,506 shJANE STREET GROUP, LLC
$547.8K63,402 shWealthspire Advisors, LLC
$410.4K47,498 shCITADEL ADVISORS LLC
$378.5K43,803 shMARSHALL WACE, LLP
$377.3K43,672 shVANGUARD FIDUCIARY TRUST CO
$335.0K38,770 sh
| Fund | Value | Shares |
|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $1.8M | 211,639 |
| FourWorld Capital Management LLC | $812.2K | 94,000 |
| WEXFORD CAPITAL LP | $795.4K | 92,060 |
| GEODE CAPITAL MANAGEMENT, LLC | $632.2K | 73,149 |
| NORTHERN TRUST CORP | $574.6K | 66,506 |
| JANE STREET GROUP, LLC | $547.8K | 63,402 |
| Wealthspire Advisors, LLC | $410.4K | 47,498 |
| CITADEL ADVISORS LLC | $378.5K | 43,803 |
| MARSHALL WACE, LLP | $377.3K | 43,672 |
| VANGUARD FIDUCIARY TRUST CO | $335.0K | 38,770 |
Companies Similar to ECOR
Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.
EXAGEN INC.
Neuronetics, Inc.
Starling Oncology, Inc.
TriSalus Life Sciences, Inc.
BIODESIX INC
CARLSMED, INC.
Ceribell, Inc.
Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.
More Healthcare Companies
View all Healthcare →Put ECOR on your watchlist
Track score changes the day electroCore, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is ECOR a good stock to buy?
13F Pro's AI-powered analysis of electroCore, Inc. (ECOR) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ECOR are available on the ECOR stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. ECOR is classified as a small company.
Which hedge funds own ECOR?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ECOR. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of electroCore, Inc.'s investment landscape.